In vivo performance of a multiparticulate matrix, controlled-release theophylline preparation

被引:4
作者
Peh, KK
Yuen, KH
机构
[1] School of Pharmaceutical Sciences, University of Science Malaysia
关键词
D O I
10.3109/03639049609042000
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An experimental multiparticulate matrix sustained-release theophylline preparation was evaluated in vivo, in comparison with Neulin-SR(R). Twelve healthy volunteers participated in the study, conducted according to a randomized, two-way crossover study design. The preparations were compared using the pharmacokinetic parameters, peak serum concentration (C-max, total area under the serum concentration-rime curve (AUC(0-infinity)), time to reach peak serum concentration (T-max), and time for 50% dose absorption in vivo (T-50%). A statistically significant difference was observed in the T-max and T-50% values (p < 0.05) but not in the logarithmic transformed values of C-max and AUC(0-infinity). These findings indicate that the two preparation are comparable in the extent but differ in the rate of absorption, with the experimental preparation being more sustained. In addition, the elimination rate constant (K-e), elimination half-life (t(1/2)), and apparent volume of distribution (V-d) of the drug were calculated. There was no statistically significant difference between the K-e, t(1/2), and V-d values obtained from the data of the two preparations. Moreover, the values obtained are comparable to those reported in the literature. A satisfactory correlation was also obtained between the mean in vivo absorption and mean in vitro dissolution data (p < 0.001) for both preparations.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 13 条
[1]  
BENEDIKT G, 1988, ARZNEIMITTEL-FORSCH, V38-2, P1203
[2]  
Gibaldi M., 1982, PHARMACOKINETICS, P145, DOI DOI 10.1111/jvp.12458
[3]  
LORDI NG, 1986, THEORY PRACTICE IND, P430
[4]   DEVELOPMENT AND IN-VITRO EVALUATION OF A NOVEL MULTIPARTICULATE MATRIX CONTROLLED-RELEASE FORMULATION OF THEOPHYLLINE [J].
PEH, KK ;
YUEN, KH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (13) :1545-1555
[5]   STATISTICAL-ANALYSIS OF BIOAVAILABILITY STUDIES - PARAMETRIC AND NONPARAMETRIC CONFIDENCE-INTERVALS [J].
STEINIJANS, VW ;
DILETTI, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (01) :127-136
[6]   BIOAVAILABILITY AND PHARMACOKINETICS OF A NEW CONTROLLED-RELEASE THEOPHYLLINE PREPARATION IN THE FORM OF CAPSULES CONTAINING PELLETS [J].
VALENTI, S ;
CRIMI, P ;
BRUSASCO, V .
RESPIRATION, 1987, 52 (03) :195-200
[7]  
Wagner J. G., 1975, FUNDAMENTALS CLIN PH, P285
[8]   KINETIC ANALYSIS OF BLOOD LEVELS + URINARY EXCRETION IN ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG [J].
WAGNER, JG ;
NELSON, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1964, 53 (11) :1392-&
[9]  
Weiner D.L., 1981, STAT PHARM IND, P205
[10]   SYMMETRICAL CONFIDENCE-INTERVALS FOR BIOEQUIVALENCE TRIALS [J].
WESTLAKE, WJ .
BIOMETRICS, 1976, 32 (04) :741-744